title: Acute respiratory insufficiency during doxorubicin, cyclophosphamide, and G-CSF therapy.
authors.forename: J B
authors.initials: JB
authors.lastname: van Woensel
authors.forename: H
authors.initials: H
authors.lastname: Knoester
authors.forename: J A
authors.initials: JA
authors.lastname: Leeuw
authors.forename: W M
authors.initials: WM
authors.lastname: van Aalderen
mesh_terms: D000208:Acute Disease; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004357:Drug Synergism; D017809:Fatal Outcome; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012131:Respiratory Insufficiency / Q000139:chemically induced*
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D003520:Cyclophosphamide; D000069585:Filgrastim